Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb

HPV-induced cervical cancer is one of the prevalent gynecological cancers world-wide. In the present study, we determined the efficacy of Minnelide, a prodrug which is converted to its active form (Triptolide) in vivo against cervical cancer cells. Our studies show that Triptolide inhibited HPV-16 a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Ramakrishnan, Vivek, de Haydu, Christopher, Wilkinson, Peter, Hooda, Urvashi, Giri, Bhuwan, Oleas, Janneth M, Rive, Veronica, Roy, Sabita, Dudeja, Vikas, Slomovitch, Brian, Saluja, Ashok, Ramakrishnan, Sundaram
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167699/
https://ncbi.nlm.nih.gov/pubmed/34094678
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars